Taheri-Araghi Sattar
Department of Physics and Astronomy, California State University, Northridge, CA, United States.
Front Microbiol. 2024 Jul 31;15:1390765. doi: 10.3389/fmicb.2024.1390765. eCollection 2024.
Antibiotic resistance is a growing global problem that requires innovative therapeutic approaches and strategies for administering antibiotics. One promising approach is combination therapy, in which two or more drugs are combined to combat an infection. Along this line, the combination of antimicrobial peptides (AMPs) with conventional antibiotics has gained attention mainly due to the complementary mechanisms of action of AMPs and conventional antibiotics. In this article, we review both and studies that explore the synergy between AMPs and antibiotics. We highlight several mechanisms through which synergy is observed in experiments, including increasing membrane permeability, disrupting biofilms, directly potentiating antibiotic efficacy, and inhibiting resistance development. Moreover, studies reveal additional mechanisms such as enhanced/modulated immune responses, reduced inflammation, and improved tissue regeneration. Together, the current literature demonstrates that AMP-antibiotic combinations can substantially enhance efficacy of antibiotic therapies, including therapies against resistant bacteria, which represents a valuable enhancement to current antimicrobial strategies.
抗生素耐药性是一个日益严重的全球性问题,需要创新的治疗方法和抗生素给药策略。一种有前景的方法是联合治疗,即联合使用两种或更多种药物来对抗感染。沿着这条思路,抗菌肽(AMPs)与传统抗生素的联合使用主要因其作用机制的互补性而受到关注。在本文中,我们回顾了探索AMPs与抗生素之间协同作用的体外和体内研究。我们强调了在体外实验中观察到协同作用的几种机制,包括增加膜通透性、破坏生物膜、直接增强抗生素疗效以及抑制耐药性发展。此外,体内研究还揭示了其他机制,如增强/调节免疫反应、减轻炎症和改善组织再生。总体而言,当前文献表明,AMPs与抗生素的联合使用可以显著提高抗生素治疗的疗效,包括针对耐药菌的治疗,这对当前的抗菌策略来说是一种有价值的提升。